Status:
COMPLETED
Kinetics of Circulating Tumoral Cells in Bronchial Primitive Cancer
Lead Sponsor:
Fondation Hôpital Saint-Joseph
Conditions:
Bronchial Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The pronostic value of Circulating Tumoral Cells(CTC) 's dosage by the method ISET® (tumoral cell isolation by size) in patients with bronchial cancer was previously demonstrated. However, no kinetic...
Eligibility Criteria
Inclusion
- patients with non-small cell lung cancer
- accepting participation
Exclusion
- refusing participation
Key Trial Info
Start Date :
March 7 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 20 2021
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT03328559
Start Date
March 7 2016
End Date
August 20 2021
Last Update
August 23 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Groupe Hospitalier Paris Saint Joseph
Paris, Île-de-France Region, France, 75014